首页> 外文期刊>Japanese Journal of Pharmacology >Effects of NTE-122, an Acyl-CoA:Cholesterol Acyltransferase Inhibitor, on Cholesterol Esterification and Lipid Secretion From CaCo-2 Cells, and Cholesterol Absorption in Rats
【24h】

Effects of NTE-122, an Acyl-CoA:Cholesterol Acyltransferase Inhibitor, on Cholesterol Esterification and Lipid Secretion From CaCo-2 Cells, and Cholesterol Absorption in Rats

机译:NTE-122,一种酰基辅酶A:胆固醇酰基转移酶抑制剂,对大鼠CaCo-2细胞的胆固醇酯化和脂质分泌以及胆固醇吸收的影响

获取原文
           

摘要

References(14) Cited-By(2) The effect of NTE-122 (trans-1, 4-bis[[1-cyclohexyl-3-(4-dimethylamino phenyl)ureido]methyl]cyclohexane), an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol absorption was investigated. NTE-122 inhibited whole-cell ACAT activity in CaCo-2 cells, a human intestinal cell line, with an IC50 value of 4.7 nM. In CaCo-2 cells cultured on a membrane filter, NTE-122 pronouncedly inhibited the basolateral secretion of newly synthesized cholesteryl esters, and significantly reduced the basolateral secretion of newly synthesized triglycerides without influencing the cellular triglyceride synthesis. Furthermore, NTE-122 (1 mg/kg, p.o.) inhibited [14C]cholesterol absorption in rats. These results suggest that NTE-122 is capable of exhibiting anti-hyperlipidemic effects by reducing the absorption of dietary cholesterol.
机译:参考文献(14)被引用的By(2)酰基-CoA的NTE-122(反式1,4-双[[1-环己基-3-(4-二甲基氨基苯基)脲基]甲基]环己烷)的作用:胆固醇酰基转移酶(ACAT)抑制剂,对胆固醇的吸收进行了研究。 NTE-122抑制人肠道细胞系CaCo-2细胞中的全细胞ACAT活性,IC50值为4.7 nM。在膜滤器上培养的CaCo-2细胞中,NTE-122明显抑制了新合成的胆固醇酯的基底外侧分泌,并显着降低了新合成的甘油三酸酯的基底外侧分泌,而不会影响细胞甘油三酸酯的合成。此外,NTE-122(1 mg / kg,p.o.)抑制大鼠中[14C]胆固醇的吸收。这些结果表明NTE-122能够通过减少饮食中胆固醇的吸收而表现出抗高血脂作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号